Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2000 Aug;76(898):473–478. doi: 10.1136/pmj.76.898.473

Mucins and inflammatory bowel disease

T Shirazi 1, R Longman 1, A Corfield 1, C Probert 1
PMCID: PMC1741691  PMID: 10908374

Abstract

There is a layer of mucus lining the gastrointestinal tract, which acts as both a lubricant and as a physical barrier between luminal contents and the mucosal surface. The mucins that make up this layer consist of a protein backbone with oligosaccharides attached to specific areas of the protein core. These areas are called the variable number tandem repeat regions. The degree of glycosylation of the mucins is central to their role in the mucus barrier. The oligosaccharides are variable and complex. It has been demonstrated that the degree of sulphation and sialylation and the length of the oligosaccharide chains all vary in inflammatory bowel disease. These changes can alter the function of the mucins. Mucins are broadly divided into two groups, those that are secreted and those that are membrane bound. The major mucins present in the colorectum are MUC1, MUC2, MUC3, and MUC4.
Trefoils are a group of small peptides that have an important role in the mucus layer. Three trefoils have been demonstrated so far. They seem to play a part in mucosal protection and in mucosal repair. They may help to stabilise the mucus layer by cross linking with mucins to aid formation of stable gels. Trefoils can be expressed in the ulcer associated cell lineage, a glandular structure that can occur in the inflamed mucosa. There seem to be differences in the expression of trefoils in the colon and the small bowel, which may imply different method of mucosal repair.


Keywords: mucins; trefoil; Crohn's disease; colitis

Full Text

The Full Text of this article is available as a PDF (267.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aslam A., Spicer R. D., Corfield A. P. Histochemical and genetic analysis of colonic mucin glycoproteins in Hirschsprung's disease. J Pediatr Surg. 1999 Feb;34(2):330–333. doi: 10.1016/s0022-3468(99)90202-6. [DOI] [PubMed] [Google Scholar]
  2. Barker R. M., Baker M. R. Incidence of cancer in Bradford Asians. J Epidemiol Community Health. 1990 Jun;44(2):125–129. doi: 10.1136/jech.44.2.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bartman A. E., Sanderson S. J., Ewing S. L., Niehans G. A., Wiehr C. L., Evans M. K., Ho S. B. Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps. Int J Cancer. 1999 Jan 18;80(2):210–218. doi: 10.1002/(sici)1097-0215(19990118)80:2<210::aid-ijc9>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  4. Blank M., Klussmann E., Krüger-Krasagakes S., Schmitt-Gräff A., Stolte M., Bornhoeft G., Stein H., Xing P. X., McKenzie I. F., Verstijnen C. P. Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types. Int J Cancer. 1994 Nov 1;59(3):301–306. doi: 10.1002/ijc.2910590302. [DOI] [PubMed] [Google Scholar]
  5. Buisine M. P., Desreumaux P., Debailleul V., Gambiez L., Geboes K., Ectors N., Delescaut M. P., Degand P., Aubert J. P., Colombel J. F. Abnormalities in mucin gene expression in Crohn's disease. Inflamm Bowel Dis. 1999 Feb;5(1):24–32. doi: 10.1097/00054725-199902000-00004. [DOI] [PubMed] [Google Scholar]
  6. Buisine M. P., Devisme L., Savidge T. C., Gespach C., Gosselin B., Porchet N., Aubert J. P. Mucin gene expression in human embryonic and fetal intestine. Gut. 1998 Oct;43(4):519–524. doi: 10.1136/gut.43.4.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Buisine M. P., Janin A., Maunoury V., Audié J. P., Delescaut M. P., Copin M. C., Colombel J. F., Degand P., Aubert J. P., Porchet N. Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma. Gastroenterology. 1996 Jan;110(1):84–91. doi: 10.1053/gast.1996.v110.pm8536891. [DOI] [PubMed] [Google Scholar]
  8. Campbell B. J., Finnie I. A., Hounsell E. F., Rhodes J. M. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. J Clin Invest. 1995 Feb;95(2):571–576. doi: 10.1172/JCI117700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Carlstedt I., Sheehan J. K., Corfield A. P., Gallagher J. T. Mucous glycoproteins: a gel of a problem. Essays Biochem. 1985;20:40–76. [PubMed] [Google Scholar]
  10. Chambers J. A., Hollingsworth M. A., Trezise A. E., Harris A. Developmental expression of mucin genes MUC1 and MUC2. J Cell Sci. 1994 Feb;107(Pt 2):413–424. doi: 10.1242/jcs.107.2.413. [DOI] [PubMed] [Google Scholar]
  11. Chinery R., Playford R. J. Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat. Clin Sci (Lond) 1995 Apr;88(4):401–403. doi: 10.1042/cs0880401. [DOI] [PubMed] [Google Scholar]
  12. Clamp J. R., Fraser G., Read A. E. Study of the carbohydrate content of mucus glycoproteins from normal and diseased colons. Clin Sci (Lond) 1981 Aug;61(2):229–234. doi: 10.1042/cs0610229. [DOI] [PubMed] [Google Scholar]
  13. Corfield A. P., Wagner S. A., O'Donnell L. J., Durdey P., Mountford R. A., Clamp J. R. The roles of enteric bacterial sialidase, sialate O-acetyl esterase and glycosulfatase in the degradation of human colonic mucin. Glycoconj J. 1993 Feb;10(1):72–81. doi: 10.1007/BF00731190. [DOI] [PubMed] [Google Scholar]
  14. Corfield A. P., Warren B. F. Mucus glycoproteins and their role in colorectal disease. J Pathol. 1996 Sep;180(1):8–17. doi: 10.1002/(SICI)1096-9896(199609)180:1<8::AID-PATH596>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  15. Gum J. R., Jr, Hicks J. W., Toribara N. W., Siddiki B., Kim Y. S. Molecular cloning of human intestinal mucin (MUC2) cDNA. Identification of the amino terminus and overall sequence similarity to prepro-von Willebrand factor. J Biol Chem. 1994 Jan 28;269(4):2440–2446. [PubMed] [Google Scholar]
  16. Gum J. R., Jr, Ho J. J., Pratt W. S., Hicks J. W., Hill A. S., Vinall L. E., Roberton A. M., Swallow D. M., Kim Y. S. MUC3 human intestinal mucin. Analysis of gene structure, the carboxyl terminus, and a novel upstream repetitive region. J Biol Chem. 1997 Oct 17;272(42):26678–26686. doi: 10.1074/jbc.272.42.26678. [DOI] [PubMed] [Google Scholar]
  17. Hanby A. M., Poulsom R., Elia G., Singh S., Longcroft J. M., Wright N. A. The expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in 'gastric metaplasia' of the proximal duodenum: implications for the nature of 'gastric metaplasia'. J Pathol. 1993 Mar;169(3):355–360. doi: 10.1002/path.1711690313. [DOI] [PubMed] [Google Scholar]
  18. Hanby A. M., Poulsom R., Singh S., Elia G., Jeffery R. E., Wright N. A. Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology. 1993 Oct;105(4):1110–1116. doi: 10.1016/0016-5085(93)90956-d. [DOI] [PubMed] [Google Scholar]
  19. Hounsell E. F., Feizi T. Gastrointestinal mucins. Structures and antigenicities of their carbohydrate chains in health and disease. Med Biol. 1982 Oct;60(5):227–236. [PubMed] [Google Scholar]
  20. Kindon H., Pothoulakis C., Thim L., Lynch-Devaney K., Podolsky D. K. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology. 1995 Aug;109(2):516–523. doi: 10.1016/0016-5085(95)90340-2. [DOI] [PubMed] [Google Scholar]
  21. Konturek P. C., Brzozowski T., Konturek S. J., Elia G., Wright N., Sliwowski Z., Thim L., Hahn E. G. Role of spasmolytic polypeptide in healing of stress-induced gastric lesions in rats. Regul Pept. 1997 Jan 15;68(1):71–79. doi: 10.1016/s0167-0115(96)02106-4. [DOI] [PubMed] [Google Scholar]
  22. Kyo K., Parkes M., Takei Y., Nishimori H., Vyas P., Satsangi J., Simmons J., Nagawa H., Baba S., Jewell D. Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3. Hum Mol Genet. 1999 Feb;8(2):307–311. doi: 10.1093/hmg/8.2.307. [DOI] [PubMed] [Google Scholar]
  23. Moniaux N., Nollet S., Porchet N., Degand P., Laine A., Aubert J. P. Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin. Biochem J. 1999 Mar 1;338(Pt 2):325–333. [PMC free article] [PubMed] [Google Scholar]
  24. Myerscough N., Warren B., Gough M., Corfield A. Expression of mucin genes in ulcerative colitis. Biochem Soc Trans. 1995 Nov;23(4):536S–536S. doi: 10.1042/bst023536s. [DOI] [PubMed] [Google Scholar]
  25. Parker N., Tsai H. H., Ryder S. D., Raouf A. H., Rhodes J. M. Increased rate of sialylation of colonic mucin by cultured ulcerative colitis mucosal explants. Digestion. 1995;56(1):52–56. doi: 10.1159/000201222. [DOI] [PubMed] [Google Scholar]
  26. Patton S., Gendler S. J., Spicer A. P. The epithelial mucin, MUC1, of milk, mammary gland and other tissues. Biochim Biophys Acta. 1995 Dec 20;1241(3):407–423. doi: 10.1016/0304-4157(95)00014-3. [DOI] [PubMed] [Google Scholar]
  27. Pigny P., Guyonnet-Duperat V., Hill A. S., Pratt W. S., Galiegue-Zouitina S., d'Hooge M. C., Laine A., Van-Seuningen I., Degand P., Gum J. R. Human mucin genes assigned to 11p15.5: identification and organization of a cluster of genes. Genomics. 1996 Dec 15;38(3):340–352. doi: 10.1006/geno.1996.0637. [DOI] [PubMed] [Google Scholar]
  28. Playford R. J., Marchbank T., Goodlad R. A., Chinery R. A., Poulsom R., Hanby A. M. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2137–2142. doi: 10.1073/pnas.93.5.2137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Playford R. J. Trefoil peptides: what are they and what do they do? J R Coll Physicians Lond. 1997 Jan-Feb;31(1):37–41. [PMC free article] [PubMed] [Google Scholar]
  30. Podolsky D. K. Healing the epithelium: solving the problem from two sides. J Gastroenterol. 1997 Feb;32(1):122–126. doi: 10.1007/BF01213309. [DOI] [PubMed] [Google Scholar]
  31. Podolsky D. K., Lynch-Devaney K., Stow J. L., Oates P., Murgue B., DeBeaumont M., Sands B. E., Mahida Y. R. Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem. 1993 Mar 25;268(9):6694–6702. [PubMed] [Google Scholar]
  32. Probert C. S., Jayanthi V., Wicks A. C., Mayberry J. F. Mortality in patients with ulcerative colitis in Leicestershire, 1972-1989. An epidemiological study. Dig Dis Sci. 1993 Mar;38(3):538–541. doi: 10.1007/BF01316511. [DOI] [PubMed] [Google Scholar]
  33. Probert C. S., Warren B. F., Perry T., Mackay E. H., Mayberry J. F., Corfield A. P. South Asian and European colitics show characteristic differences in colonic mucus glycoprotein type and turnover. Gut. 1995 May;36(5):696–702. doi: 10.1136/gut.36.5.696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Pullan R. D., Thomas G. A., Rhodes M., Newcombe R. G., Williams G. T., Allen A., Rhodes J. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut. 1994 Mar;35(3):353–359. doi: 10.1136/gut.35.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Raouf A. H., Tsai H. H., Parker N., Hoffman J., Walker R. J., Rhodes J. M. Sulphation of colonic and rectal mucin in inflammatory bowel disease: reduced sulphation of rectal mucus in ulcerative colitis. Clin Sci (Lond) 1992 Nov;83(5):623–626. doi: 10.1042/cs0830623. [DOI] [PubMed] [Google Scholar]
  36. Reid C. J., Harris A. Developmental expression of mucin genes in the human gastrointestinal system. Gut. 1998 Feb;42(2):220–226. doi: 10.1136/gut.42.2.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Rhodes J. M. Mucins and inflammatory bowel disease. QJM. 1997 Feb;90(2):79–82. doi: 10.1093/qjmed/90.2.79. [DOI] [PubMed] [Google Scholar]
  38. Rio M. C., Bellocq J. P., Daniel J. Y., Tomasetto C., Lathe R., Chenard M. P., Batzenschlager A., Chambon P. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science. 1988 Aug 5;241(4866):705–708. doi: 10.1126/science.3041593. [DOI] [PubMed] [Google Scholar]
  39. Sands B. E., Podolsky D. K. The trefoil peptide family. Annu Rev Physiol. 1996;58:253–273. doi: 10.1146/annurev.ph.58.030196.001345. [DOI] [PubMed] [Google Scholar]
  40. Strous G. J., Dekker J. Mucin-type glycoproteins. Crit Rev Biochem Mol Biol. 1992;27(1-2):57–92. doi: 10.3109/10409239209082559. [DOI] [PubMed] [Google Scholar]
  41. Suemori S., Lynch-Devaney K., Podolsky D. K. Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11017–11021. doi: 10.1073/pnas.88.24.11017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Tanaka S., Podolsky D. K., Engel E., Guth P. H., Kaunitz J. D. Human spasmolytic polypeptide decreases proton permeation through gastric mucus in vivo and in vitro. Am J Physiol. 1997 Jun;272(6 Pt 1):G1473–G1480. doi: 10.1152/ajpgi.1997.272.6.G1473. [DOI] [PubMed] [Google Scholar]
  43. Tsai H. H., Dwarakanath A. D., Hart C. A., Milton J. D., Rhodes J. M. Increased faecal mucin sulphatase activity in ulcerative colitis: a potential target for treatment. Gut. 1995 Apr;36(4):570–576. doi: 10.1136/gut.36.4.570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Tytgat K. M., Büller H. A., Opdam F. J., Kim Y. S., Einerhand A. W., Dekker J. Biosynthesis of human colonic mucin: Muc2 is the prominent secretory mucin. Gastroenterology. 1994 Nov;107(5):1352–1363. doi: 10.1016/0016-5085(94)90537-1. [DOI] [PubMed] [Google Scholar]
  45. Weiss A. A., Babyatsky M. W., Ogata S., Chen A., Itzkowitz S. H. Expression of MUC2 and MUC3 mRNA in human normal, malignant, and inflammatory intestinal tissues. J Histochem Cytochem. 1996 Oct;44(10):1161–1166. doi: 10.1177/44.10.8813081. [DOI] [PubMed] [Google Scholar]
  46. Wright N. A., Pike C., Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature. 1990 Jan 4;343(6253):82–85. doi: 10.1038/343082a0. [DOI] [PubMed] [Google Scholar]
  47. Wright N. A., Poulsom R., Stamp G. W., Hall P. A., Jeffery R. E., Longcroft J. M., Rio M. C., Tomasetto C., Chambon P. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol. 1990 Dec;162(4):279–284. doi: 10.1002/path.1711620402. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES